GWLL — Goldenwell Biotech Balance Sheet
0.000.00%
- $64.35m
- $64.48m
- $0.00m
Annual balance sheet for Goldenwell Biotech, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | R2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 0.214 | 0.046 | 0.053 | 0.049 | 0.027 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | — | 0 | — | — | — |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 0.412 | 0.222 | 0.228 | 0.224 | 0.036 |
| Net Property, Plant And Equipment | 0.049 | 0.026 | — | — | 0 |
| Other Long Term Assets | |||||
| Total Assets | 0.461 | 0.248 | 0.228 | 0.224 | 0.036 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.159 | 0.027 | 0.002 | 0.002 | 0.102 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 0.159 | 0.047 | 0.144 | 0.271 | 0.38 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 0.302 | 0.202 | 0.084 | -0.047 | -0.344 |
| Total Liabilities & Shareholders' Equity | 0.461 | 0.248 | 0.228 | 0.224 | 0.036 |
| Total Common Shares Outstanding |